AU2002343199A1 - Formulations of erythromycin derivatives with improved bioavailability - Google Patents

Formulations of erythromycin derivatives with improved bioavailability

Info

Publication number
AU2002343199A1
AU2002343199A1 AU2002343199A AU2002343199A AU2002343199A1 AU 2002343199 A1 AU2002343199 A1 AU 2002343199A1 AU 2002343199 A AU2002343199 A AU 2002343199A AU 2002343199 A AU2002343199 A AU 2002343199A AU 2002343199 A1 AU2002343199 A1 AU 2002343199A1
Authority
AU
Australia
Prior art keywords
formulations
improved bioavailability
erythromycin derivatives
erythromycin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002343199A
Other versions
AU2002343199A8 (en
Inventor
Madhukant Mansukhlal Doshi
Milind Dattatraya Joshi
Bharat Pravinchandra Mehta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JB Chemicals and Pharmaceuticals Ltd
Original Assignee
JB Chemicals and Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JB Chemicals and Pharmaceuticals Ltd filed Critical JB Chemicals and Pharmaceuticals Ltd
Publication of AU2002343199A1 publication Critical patent/AU2002343199A1/en
Publication of AU2002343199A8 publication Critical patent/AU2002343199A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2002343199A 2002-05-28 2002-09-05 Formulations of erythromycin derivatives with improved bioavailability Abandoned AU2002343199A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15638302A 2002-05-28 2002-05-28
US10/156,383 2002-05-28
PCT/IN2002/000183 WO2003099197A2 (en) 2002-05-28 2002-09-05 Formulations of erythromycin derivatives with improved bioavailability

Publications (2)

Publication Number Publication Date
AU2002343199A1 true AU2002343199A1 (en) 2003-12-12
AU2002343199A8 AU2002343199A8 (en) 2003-12-12

Family

ID=29582246

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002343199A Abandoned AU2002343199A1 (en) 2002-05-28 2002-09-05 Formulations of erythromycin derivatives with improved bioavailability

Country Status (2)

Country Link
AU (1) AU2002343199A1 (en)
WO (1) WO2003099197A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2283824B1 (en) 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin
CN102552172B (en) * 2012-03-21 2013-03-20 广州共禾医药科技有限公司 Roxithromycin controlled-release preparation and preparation method thereof
CN102920680A (en) * 2012-11-29 2013-02-13 康普药业股份有限公司 Roxithromycin capsule and preparation method thereof
CN109364040B (en) * 2018-10-18 2020-01-14 珠海安生凤凰制药有限公司 Roxithromycin capsule and production process thereof
CN110548010A (en) * 2019-04-02 2019-12-10 海南海神同洲制药有限公司 preparation method of roxithromycin dispersible tablet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500422D0 (en) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms

Also Published As

Publication number Publication date
AU2002343199A8 (en) 2003-12-12
WO2003099197A2 (en) 2003-12-04
WO2003099197A3 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
AU2004266485A1 (en) Phenoxiacetic acid derivatives
AU2002363005A1 (en) Derivatives of uk-2a
AU2003296897A1 (en) Pharmaceutical formulations of camptothecine derivatives
EP1682493B8 (en) Amidoacetonitrile derivatives
AU2003298738A1 (en) Liposomal formulations
AU2002349676A1 (en) 4-oxoquinoline derivatives
EP1606277B8 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
AU2003901813A0 (en) Pharmaceutical derivatives
AU2003227792A1 (en) Lignan formulations
AU2003301968A1 (en) 4-aminomethyl-1-aryl-cyclohexylamine derivatives
AU2003303648A1 (en) Novel 5-hydroxyindole-3-carboxylate derivatives
EP1706373B8 (en) Amidoacetonitrile derivatives
AU2003296564A1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AU2003234131A1 (en) 5-o-mycaminosyltylonide derivatives
AU2002350942A1 (en) Imidazolidineacetic acid derivatives
AU2002343199A1 (en) Formulations of erythromycin derivatives with improved bioavailability
AU2003238180A1 (en) 2-naphtamide derivatives
AU2002249639A1 (en) Pyranocoumarin derivatives
AU2003273398A1 (en) Aroyl-piperidine derivatives
AU2003304705A1 (en) 11-csubsituted erythromycin derivatives
AU2003288012A1 (en) Isothiazolyl-benzoxazine derivatives
AU2003284704A1 (en) Substituted 1h-pyridine-2-one derivatives
AU2003201621A1 (en) Lignan derivatives
AU2003243397A1 (en) Homo-camptothecin derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase